Literature DB >> 31141851

Optimizing Patient Outcomes by Customizing Treatment With Microfocused Ultrasound With Visualization: Gold Standard Consensus Guidelines from an Expert Panel

Sabrina G. Fabi, John Joseph, Julia Sevi, Jeremy B. Green, Jennifer Deaver Peterson.   

Abstract

Background: Microfocused ultrasound with visualization (MFU-V) has emerged as a safe and reliable means for lifting and tightening lax skin. Although patients may present with similar age-related changes in the skin and connective tissue, MFU-V treatment must be customized for each patient. Objective: The following guidelines were prepared to provide a framework for clinicians to develop a customized treatment plan based on the proper use of ultrasound imaging and key patient characteristics to achieve good clinical outcomes with MFU-V. Methods and Materials: A panel of five expert aesthetic physicians convened to discuss recommendations on the use of MFU-V. Topics included patient factors contributing to favorable outcomes; customizing the number of treatment lines, energy settings, and treatment depths; approaches for restorative vs preventative vs maintenance treatments; and important safety considerations.
Results: Ultrasound imaging is important for selecting transducers and treatment depth and planning the number of treatment lines at each depth. Ideal outcomes are associated with higher density treatments. Treatment intervals are tailored to age, with older patients requiring more frequent treatments to maintain results. MFU-V can be applied for both preventative and restorative treatments. Managing patient expectations is essential.
Conclusion: Supported by a large body of clinical evidence, a well-characterized mechanism of action, and high patient satisfaction, MFU-V is considered by the expert panel of physicians to be a key foundation of aesthetic treatment and the gold standard for nonsurgical lifting and skin tightening.

Entities:  

Mesh:

Year:  2019        PMID: 31141851

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  6 in total

Review 1.  Insights on Skin Quality and Clinical Practice Trends in Asia Pacific and a Practical Guide to Good Skin Quality from the Inside Out.

Authors:  Je-Young Park; Jeng-Feng Chen; Hosung Choi; Wilson W S Ho; Ni Nyoman Indra Lesthari; Joyce Teng Ee Lim; Ting Song Lim; Stephen Lowe; Beverly Ong-Amoranto; Vasanop Vachiramon; Rungsima Wanitphakdeedecha; Martina Kerscher
Journal:  J Clin Aesthet Dermatol       Date:  2022-06

2.  Customized Treatment Using Microfocused Ultrasound with Visualization for Optimized Patient Outcomes: A Review of Skin-tightening Energy Technologies and a Pan-Asian Adaptation of the Expert Panel's Gold Standard Consensus.

Authors:  Je-Young Park; Frank Lin; Atchima Suwanchinda; Rungsima Wanitphakdeedecha; Jonathan Yu; Ting Song Lim; Jeng Feng Chen; Wilson Ho; Joyce Lim; Lanny Juniarty; Yong Seng Kee; Seong Jae Youn; Sabrina Fabi
Journal:  J Clin Aesthet Dermatol       Date:  2021-05-01

3.  Effectiveness of combined microfocused ultrasound with visualization and subdermal calcium hydroxyapatite injections for the management of brachial skin laxity.

Authors:  Sylvia Ramirez; Ivan Boon Kwang Puah
Journal:  J Cosmet Dermatol       Date:  2021-10-29       Impact factor: 2.189

4.  Microfocused Ultrasound with Visualization for Face Slimming: Preliminary Results in Four Women.

Authors:  Talitha Possagno Chaves Bellote; Helio Amante Miot
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-11-03

5.  Single Treatment, Single Depth Superficial Microfocused Ultrasound with Visualization for Rhytid Improvement.

Authors:  Stephen Lowe
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-07-13

6.  Microfocused ultrasound with visualization: Consensus on safety and review of energy-based devices.

Authors:  Tatjana Pavicic; John R Ballard; Tatiana Bykovskaya; Niamh Corduff; Cyro Hirano; Je-Young Park; Alena Saromytskaya; Julia Sevi; Suyan Vasconcelos
Journal:  J Cosmet Dermatol       Date:  2021-12-24       Impact factor: 2.189

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.